Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
about
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies.Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.Targeted therapy in sarcomas other than GIST tumorsCrizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell linesXenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agentsThe HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.Emerging approaches for histone deacetylase inhibitor drug discovery.Therapeutic applications of histone deacetylase inhibitors in sarcoma.Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.HDAC inhibitors enhance the immunotherapy response of melanoma cells.The role of tumor microenvironment in resistance to anti-angiogenic therapy.
P2860
Q33420276-86F5B1E3-FC9C-4111-9433-C34845796C61Q33439519-985A6449-71BA-498A-8CDC-BE42B46FE1ABQ34366102-A2E536F0-06A0-41A7-9E66-88D239E19E85Q35622367-80E4ED76-B94D-49F4-9F79-AA45F44D97D6Q36545596-523C3CF8-5F50-4687-8DED-113F334F3DC3Q37106770-57AD07DB-FAD9-41A2-BFBA-CB13C68FB9AFQ37725434-D9D5E4EC-FEC3-4693-BD26-641282330B7CQ38431356-7BB340C9-6E0D-45B8-91EC-BEDA85A65186Q39450827-7FD084FA-E33D-4EE2-B1D9-57262B96886FQ39956277-8A8C1E0B-8906-4757-B678-F9B6C0A40512Q41105379-E1C853C5-1106-4BAB-BD2D-CCEADE8BDDC0Q45072959-091576D6-C012-4EFB-A0F7-37E5D3D21425Q52645823-FD5E4F5B-02C4-4101-A3BF-C681E2F29FCE
P2860
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@ast
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@en
type
label
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@ast
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@en
prefLabel
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@ast
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@en
P2093
P2860
P356
P1476
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
@en
P2093
Andrew Poklepovic
Hossein A Hamed
Seyedmehrad Tavallai
Steven Grant
P2860
P304
P356
10.4161/CBT.28163
P50
P577
2014-02-20T00:00:00Z